首页> 外文OA文献 >From Materia Medica to the Pharmacopoeia:Challenges of Writing the History of Drugs in India
【2h】

From Materia Medica to the Pharmacopoeia:Challenges of Writing the History of Drugs in India

机译:从本草到药典:印度药物史写作的挑战

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Historians of indigenous medicine in colonial India have looked more closely at the changes, reinventions and reformulations of institutions of Ayurveda and Unani than at the cognitive content of the drugs themselves. The few historians who have examined the changing content of indigenous medicines have conceptualised the creation of materia medica of Indian drugs through two tropes: one of circulation (of specific drugs) through epistemological and geographic boundaries and the second, of marginalisation of certain other drugs either through a lack of textual legitimacy or the lack of the newly discovered ‘active principles’ within each drug. While these approaches have been useful, there is a case to be made for understanding the creation of formularies of Indian drugs in 19th and 20th centuries through the prism of medical praxis in India.
机译:印度殖民地土著医学的历史学家们更密切地关注了阿育吠陀和乌纳尼机构的变化,重新发明和重新制定,而不是毒品本身的认知内容。少数研究土著药物含量变化的历史学家已经通过两种趋向来概念化印度药物的创造:一种是通过认识论和地理界限流通(特定药物),其次是某些其他药物的边缘化通过缺乏文本合法性或每种药物中缺乏新发现的“有效原则”。尽管这些方法很有用,但仍有必要通过印度的医学实践来了解19世纪和20世纪印度药物配方的创建。

著录项

  • 作者

    Bhattacharya Nandini;

  • 作者单位
  • 年度 2016
  • 总页数
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号